Loading…

7‐Tesla Magnetic Resonance Imaging for Brain Iron Quantification in Homozygous and Heterozygous PANK2 Mutation Carriers

Pantothenate‐kinase–associated neurodegeneration (PKAN) is an autosomal recessive disorder characterized by iron deposits in basal ganglia. The aim of this study was to quantify iron concentrations of deep gray matter structures in heterozygous PANK2 mutation carriers and in PKAN patients using quan...

Full description

Saved in:
Bibliographic Details
Published in:Movement disorders clinical practice (Hoboken, N.J.) N.J.), 2014-12, Vol.1 (4), p.329-335
Main Authors: Dusek, Petr, Tovar Martinez, Elena Maria, Madai, Vince Istvan, Jech, Robert, Sobesky, Jan, Paul, Friedemann, Niendorf, Thoralf, Wuerfel, Jens, Schneider, Susanne A.
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 335
container_issue 4
container_start_page 329
container_title Movement disorders clinical practice (Hoboken, N.J.)
container_volume 1
creator Dusek, Petr
Tovar Martinez, Elena Maria
Madai, Vince Istvan
Jech, Robert
Sobesky, Jan
Paul, Friedemann
Niendorf, Thoralf
Wuerfel, Jens
Schneider, Susanne A.
description Pantothenate‐kinase–associated neurodegeneration (PKAN) is an autosomal recessive disorder characterized by iron deposits in basal ganglia. The aim of this study was to quantify iron concentrations of deep gray matter structures in heterozygous PANK2 mutation carriers and in PKAN patients using quantitative susceptibility mapping MRI. By determining iron concentration, we intended to find mutation‐specific brain parenchymal stigmata in heterozygous PANK2 mutation carriers in comparison to age‐matched healthy volunteers. We studied 11 heterozygous PANK2 gene mutation carriers (mean age: 43.4 years; standard deviation [SD]: 10.5), who were found to be clinically asymptomatic by neurological examination. These carriers were compared to 2 clinically affected PKAN patients 21 and 32 years of age and to 13 age‐matched, healthy controls (mean age: 39.7; SD, 13.6). Scanning was performed on a 7.0‐Tesla whole‐body scanner applying three‐dimensional susceptibility‐weighted gradient echo acquisitions. Susceptibility maps were calculated by threshold‐based k‐space division with single‐orientation acquisition. Magnetic susceptibility values, relative to the occipital white matter, were determined for the following regions of interest (ROI): globus pallidus (GP), thalamus, putamen, internal capsule (IC), caudate nucleus, substantia nigra (SN), and red nucleus. Heterozygous PANK2 mutation carriers did not show increased brain iron concentrations, compared to healthy controls (P > 0.05), in any of the examined ROIs. In PKAN patients, more than 3 times higher concentrations of iron were found in the GP, SN, and IC. Our results suggest that heterozygous mutations in PANK2 gene do not cause brain iron accumulation nor do they cause movement disorders.
doi_str_mv 10.1002/mdc3.12080
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6183259</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2126905350</sourcerecordid><originalsourceid>FETCH-LOGICAL-p3440-efb5ee0fdf561c03e74233976a847fa286d12e85fd3e4e664277a22bcb4208bb3</originalsourceid><addsrcrecordid>eNpVUU1P3DAQtapWgCgXfkDlYy8LYztxkkslulB2VbZfomdrkkxSV4m92EnRcuIn8Bv7SxpYQPQ0M2-e3mjeY-xQwJEAkMd9XakjISGHV2xPKgUzoUXx-kW_yw5i_A0AQqYapNhhuwqUVoXI99gm-3t7d0mxQ77C1tFgK_6DonfoKuLLHlvrWt74wD8GtI4vg3f8-4husI2tcLDTOMEL3_ubTevHyNHVfEEDhSfg28mXz5KvxmHLnmMIlkJ8y9402EU6eKz77Oens8v5Ynbx9Xw5P7mYrVWSwIyaMiWCpm5SLSpQlCXTZ0WmMU-yBmWuayEpT5taUUJaJzLLUMqyKpPJlLJU--zDVnc9lj3VFbkhYGfWwfYYNsajNf9vnP1lWv_HaJErmRaTwPtHgeCvRoqD6W2sqOvQ0fSfkULqAlKVwkR99_LW85EnvyeC2BKubUeb570Acx-muQ_TPIRpVqdz9dCpfzITlAc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2126905350</pqid></control><display><type>article</type><title>7‐Tesla Magnetic Resonance Imaging for Brain Iron Quantification in Homozygous and Heterozygous PANK2 Mutation Carriers</title><source>PubMed (Medline)</source><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Dusek, Petr ; Tovar Martinez, Elena Maria ; Madai, Vince Istvan ; Jech, Robert ; Sobesky, Jan ; Paul, Friedemann ; Niendorf, Thoralf ; Wuerfel, Jens ; Schneider, Susanne A.</creator><creatorcontrib>Dusek, Petr ; Tovar Martinez, Elena Maria ; Madai, Vince Istvan ; Jech, Robert ; Sobesky, Jan ; Paul, Friedemann ; Niendorf, Thoralf ; Wuerfel, Jens ; Schneider, Susanne A.</creatorcontrib><description>Pantothenate‐kinase–associated neurodegeneration (PKAN) is an autosomal recessive disorder characterized by iron deposits in basal ganglia. The aim of this study was to quantify iron concentrations of deep gray matter structures in heterozygous PANK2 mutation carriers and in PKAN patients using quantitative susceptibility mapping MRI. By determining iron concentration, we intended to find mutation‐specific brain parenchymal stigmata in heterozygous PANK2 mutation carriers in comparison to age‐matched healthy volunteers. We studied 11 heterozygous PANK2 gene mutation carriers (mean age: 43.4 years; standard deviation [SD]: 10.5), who were found to be clinically asymptomatic by neurological examination. These carriers were compared to 2 clinically affected PKAN patients 21 and 32 years of age and to 13 age‐matched, healthy controls (mean age: 39.7; SD, 13.6). Scanning was performed on a 7.0‐Tesla whole‐body scanner applying three‐dimensional susceptibility‐weighted gradient echo acquisitions. Susceptibility maps were calculated by threshold‐based k‐space division with single‐orientation acquisition. Magnetic susceptibility values, relative to the occipital white matter, were determined for the following regions of interest (ROI): globus pallidus (GP), thalamus, putamen, internal capsule (IC), caudate nucleus, substantia nigra (SN), and red nucleus. Heterozygous PANK2 mutation carriers did not show increased brain iron concentrations, compared to healthy controls (P &gt; 0.05), in any of the examined ROIs. In PKAN patients, more than 3 times higher concentrations of iron were found in the GP, SN, and IC. Our results suggest that heterozygous mutations in PANK2 gene do not cause brain iron accumulation nor do they cause movement disorders.</description><identifier>ISSN: 2330-1619</identifier><identifier>EISSN: 2330-1619</identifier><identifier>DOI: 10.1002/mdc3.12080</identifier><identifier>PMID: 30363918</identifier><language>eng</language><publisher>United States: John Wiley and Sons Inc</publisher><subject>7‐Tesla MRI ; iron ; neurodegeneration with brain iron accumulation (NBIA) ; pantothenate kinase associated neurodegeneration (PKAN) ; quantitative susceptibility mapping</subject><ispartof>Movement disorders clinical practice (Hoboken, N.J.), 2014-12, Vol.1 (4), p.329-335</ispartof><rights>2014 International Parkinson and Movement Disorder Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-4877-9642</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183259/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183259/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30363918$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dusek, Petr</creatorcontrib><creatorcontrib>Tovar Martinez, Elena Maria</creatorcontrib><creatorcontrib>Madai, Vince Istvan</creatorcontrib><creatorcontrib>Jech, Robert</creatorcontrib><creatorcontrib>Sobesky, Jan</creatorcontrib><creatorcontrib>Paul, Friedemann</creatorcontrib><creatorcontrib>Niendorf, Thoralf</creatorcontrib><creatorcontrib>Wuerfel, Jens</creatorcontrib><creatorcontrib>Schneider, Susanne A.</creatorcontrib><title>7‐Tesla Magnetic Resonance Imaging for Brain Iron Quantification in Homozygous and Heterozygous PANK2 Mutation Carriers</title><title>Movement disorders clinical practice (Hoboken, N.J.)</title><addtitle>Mov Disord Clin Pract</addtitle><description>Pantothenate‐kinase–associated neurodegeneration (PKAN) is an autosomal recessive disorder characterized by iron deposits in basal ganglia. The aim of this study was to quantify iron concentrations of deep gray matter structures in heterozygous PANK2 mutation carriers and in PKAN patients using quantitative susceptibility mapping MRI. By determining iron concentration, we intended to find mutation‐specific brain parenchymal stigmata in heterozygous PANK2 mutation carriers in comparison to age‐matched healthy volunteers. We studied 11 heterozygous PANK2 gene mutation carriers (mean age: 43.4 years; standard deviation [SD]: 10.5), who were found to be clinically asymptomatic by neurological examination. These carriers were compared to 2 clinically affected PKAN patients 21 and 32 years of age and to 13 age‐matched, healthy controls (mean age: 39.7; SD, 13.6). Scanning was performed on a 7.0‐Tesla whole‐body scanner applying three‐dimensional susceptibility‐weighted gradient echo acquisitions. Susceptibility maps were calculated by threshold‐based k‐space division with single‐orientation acquisition. Magnetic susceptibility values, relative to the occipital white matter, were determined for the following regions of interest (ROI): globus pallidus (GP), thalamus, putamen, internal capsule (IC), caudate nucleus, substantia nigra (SN), and red nucleus. Heterozygous PANK2 mutation carriers did not show increased brain iron concentrations, compared to healthy controls (P &gt; 0.05), in any of the examined ROIs. In PKAN patients, more than 3 times higher concentrations of iron were found in the GP, SN, and IC. Our results suggest that heterozygous mutations in PANK2 gene do not cause brain iron accumulation nor do they cause movement disorders.</description><subject>7‐Tesla MRI</subject><subject>iron</subject><subject>neurodegeneration with brain iron accumulation (NBIA)</subject><subject>pantothenate kinase associated neurodegeneration (PKAN)</subject><subject>quantitative susceptibility mapping</subject><issn>2330-1619</issn><issn>2330-1619</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpVUU1P3DAQtapWgCgXfkDlYy8LYztxkkslulB2VbZfomdrkkxSV4m92EnRcuIn8Bv7SxpYQPQ0M2-e3mjeY-xQwJEAkMd9XakjISGHV2xPKgUzoUXx-kW_yw5i_A0AQqYapNhhuwqUVoXI99gm-3t7d0mxQ77C1tFgK_6DonfoKuLLHlvrWt74wD8GtI4vg3f8-4husI2tcLDTOMEL3_ubTevHyNHVfEEDhSfg28mXz5KvxmHLnmMIlkJ8y9402EU6eKz77Oens8v5Ynbx9Xw5P7mYrVWSwIyaMiWCpm5SLSpQlCXTZ0WmMU-yBmWuayEpT5taUUJaJzLLUMqyKpPJlLJU--zDVnc9lj3VFbkhYGfWwfYYNsajNf9vnP1lWv_HaJErmRaTwPtHgeCvRoqD6W2sqOvQ0fSfkULqAlKVwkR99_LW85EnvyeC2BKubUeb570Acx-muQ_TPIRpVqdz9dCpfzITlAc</recordid><startdate>201412</startdate><enddate>201412</enddate><creator>Dusek, Petr</creator><creator>Tovar Martinez, Elena Maria</creator><creator>Madai, Vince Istvan</creator><creator>Jech, Robert</creator><creator>Sobesky, Jan</creator><creator>Paul, Friedemann</creator><creator>Niendorf, Thoralf</creator><creator>Wuerfel, Jens</creator><creator>Schneider, Susanne A.</creator><general>John Wiley and Sons Inc</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4877-9642</orcidid></search><sort><creationdate>201412</creationdate><title>7‐Tesla Magnetic Resonance Imaging for Brain Iron Quantification in Homozygous and Heterozygous PANK2 Mutation Carriers</title><author>Dusek, Petr ; Tovar Martinez, Elena Maria ; Madai, Vince Istvan ; Jech, Robert ; Sobesky, Jan ; Paul, Friedemann ; Niendorf, Thoralf ; Wuerfel, Jens ; Schneider, Susanne A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p3440-efb5ee0fdf561c03e74233976a847fa286d12e85fd3e4e664277a22bcb4208bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>7‐Tesla MRI</topic><topic>iron</topic><topic>neurodegeneration with brain iron accumulation (NBIA)</topic><topic>pantothenate kinase associated neurodegeneration (PKAN)</topic><topic>quantitative susceptibility mapping</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dusek, Petr</creatorcontrib><creatorcontrib>Tovar Martinez, Elena Maria</creatorcontrib><creatorcontrib>Madai, Vince Istvan</creatorcontrib><creatorcontrib>Jech, Robert</creatorcontrib><creatorcontrib>Sobesky, Jan</creatorcontrib><creatorcontrib>Paul, Friedemann</creatorcontrib><creatorcontrib>Niendorf, Thoralf</creatorcontrib><creatorcontrib>Wuerfel, Jens</creatorcontrib><creatorcontrib>Schneider, Susanne A.</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Movement disorders clinical practice (Hoboken, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dusek, Petr</au><au>Tovar Martinez, Elena Maria</au><au>Madai, Vince Istvan</au><au>Jech, Robert</au><au>Sobesky, Jan</au><au>Paul, Friedemann</au><au>Niendorf, Thoralf</au><au>Wuerfel, Jens</au><au>Schneider, Susanne A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>7‐Tesla Magnetic Resonance Imaging for Brain Iron Quantification in Homozygous and Heterozygous PANK2 Mutation Carriers</atitle><jtitle>Movement disorders clinical practice (Hoboken, N.J.)</jtitle><addtitle>Mov Disord Clin Pract</addtitle><date>2014-12</date><risdate>2014</risdate><volume>1</volume><issue>4</issue><spage>329</spage><epage>335</epage><pages>329-335</pages><issn>2330-1619</issn><eissn>2330-1619</eissn><abstract>Pantothenate‐kinase–associated neurodegeneration (PKAN) is an autosomal recessive disorder characterized by iron deposits in basal ganglia. The aim of this study was to quantify iron concentrations of deep gray matter structures in heterozygous PANK2 mutation carriers and in PKAN patients using quantitative susceptibility mapping MRI. By determining iron concentration, we intended to find mutation‐specific brain parenchymal stigmata in heterozygous PANK2 mutation carriers in comparison to age‐matched healthy volunteers. We studied 11 heterozygous PANK2 gene mutation carriers (mean age: 43.4 years; standard deviation [SD]: 10.5), who were found to be clinically asymptomatic by neurological examination. These carriers were compared to 2 clinically affected PKAN patients 21 and 32 years of age and to 13 age‐matched, healthy controls (mean age: 39.7; SD, 13.6). Scanning was performed on a 7.0‐Tesla whole‐body scanner applying three‐dimensional susceptibility‐weighted gradient echo acquisitions. Susceptibility maps were calculated by threshold‐based k‐space division with single‐orientation acquisition. Magnetic susceptibility values, relative to the occipital white matter, were determined for the following regions of interest (ROI): globus pallidus (GP), thalamus, putamen, internal capsule (IC), caudate nucleus, substantia nigra (SN), and red nucleus. Heterozygous PANK2 mutation carriers did not show increased brain iron concentrations, compared to healthy controls (P &gt; 0.05), in any of the examined ROIs. In PKAN patients, more than 3 times higher concentrations of iron were found in the GP, SN, and IC. Our results suggest that heterozygous mutations in PANK2 gene do not cause brain iron accumulation nor do they cause movement disorders.</abstract><cop>United States</cop><pub>John Wiley and Sons Inc</pub><pmid>30363918</pmid><doi>10.1002/mdc3.12080</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-4877-9642</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2330-1619
ispartof Movement disorders clinical practice (Hoboken, N.J.), 2014-12, Vol.1 (4), p.329-335
issn 2330-1619
2330-1619
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6183259
source PubMed (Medline); Wiley-Blackwell Read & Publish Collection
subjects 7‐Tesla MRI
iron
neurodegeneration with brain iron accumulation (NBIA)
pantothenate kinase associated neurodegeneration (PKAN)
quantitative susceptibility mapping
title 7‐Tesla Magnetic Resonance Imaging for Brain Iron Quantification in Homozygous and Heterozygous PANK2 Mutation Carriers
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T02%3A07%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=7%E2%80%90Tesla%20Magnetic%20Resonance%20Imaging%20for%20Brain%20Iron%20Quantification%20in%20Homozygous%20and%20Heterozygous%20PANK2%20Mutation%20Carriers&rft.jtitle=Movement%20disorders%20clinical%20practice%20(Hoboken,%20N.J.)&rft.au=Dusek,%20Petr&rft.date=2014-12&rft.volume=1&rft.issue=4&rft.spage=329&rft.epage=335&rft.pages=329-335&rft.issn=2330-1619&rft.eissn=2330-1619&rft_id=info:doi/10.1002/mdc3.12080&rft_dat=%3Cproquest_pubme%3E2126905350%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p3440-efb5ee0fdf561c03e74233976a847fa286d12e85fd3e4e664277a22bcb4208bb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2126905350&rft_id=info:pmid/30363918&rfr_iscdi=true